Patent details
EP2890397
Title:
ANTI-PROLACTIN RECEPTOR ANTIBODY FORMULATIONS
Basic Information
- Publication number:
- EP2890397
- PCT Application Number:
- US2013056976
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP137601803
- PCT Publication Number:
- WO2014036076
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTI-PROLACTIN RECEPTOR ANTIBODY FORMULATIONS
- French Title of Invention:
- FORMULATIONS D'ANTICORPS ANTI-RÉCEPTEURS DE PROLACTINE
- German Title of Invention:
- ANTI-PROLACTINREZEPTOR ANTIKÖRPERFORMULIERUNGEN
- SPC Number:
-
Dates
- Filing date:
- 28/08/2013
- Grant date:
- 19/06/2019
- EP Publication Date:
- 08/07/2015
- PCT Publication Date:
- 06/03/2014
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 19/06/2019
- EP B1 Publication Date:
- 19/06/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 28/08/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/06/2019
-
-
- Name:
- Bayer HealthCare LLC
- Address:
- 100 Bayer Boulevard, Whippany, NJ 07981-0915, United States (US)
Agent
- Name:
- ARONOVA S.A.
- From:
- 01/08/2019
- Address:
- PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Inventor
1
- Name:
- MA, Xinghang
- Address:
- United States (US)
2
- Name:
- XIANG, Jun
- Address:
- United States (US)
3
- Name:
- NIU, Jianjie
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201261695949 P
- Priority Date:
- 31/08/2012
- Priority Country:
- United States (US)
2
- Priority Number:
- 201313842906
- Priority Date:
- 15/03/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 39/395;
A61P 5/00;
C07K 16/28;
Publication
European Patent Bulletin
- Issue number:
- 201925
- Publication date:
- 19/06/2019
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 31/08/2026
- Annual Fee Number:
- 14
- Annual Fee Amount:
- 198 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 14/08/2025
- Last Annual Fee Paid Number:
- 13
- Last Annual Fee Paid Amount:
- 180 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM